At a Glance
| Memantine | 3-MeO-PCMo | |
|---|---|---|
| Class | Dissociatives | Dissociatives |
| Common Dose (oral) | 70–110 mg | 200–300 mg |
| Total Duration | 5.5–18 hrs | 3–5 hrs |
| Routes | oral | oral |
| Effects | 77 documented | 36 documented |
Memantine, a Dissociatives, and 3-MeO-PCMo, a Dissociatives, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Dissociativess, meaning they share a common pharmacological foundation. They share 31 documented effects in common, with 46 effects unique to Memantine and 5 unique to 3-MeO-PCMo. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Memantine | 3-MeO-PCMo | |
|---|---|---|
| Class | Dissociatives | Dissociatives |
| Common Dose (oral) | 70–110 mg | 200–300 mg |
| Total Duration | 5.5–18 hrs | 3–5 hrs |
| Routes | oral | oral |
| Effects | 77 documented | 36 documented |
| Interaction |
| Caution |
| Level | Memantine | 3-MeO-PCMo |
|---|---|---|
| Threshold | 10 mg | 50 mg |
| Light | 30–70 mg | 100–200 mg |
| Common | 70–110 mg | 200–300 mg |
| Strong | 110–170 mg | 300–400 mg |
| Heavy | 170 mg | 400 mg |
Memantine
3-MeO-PCMo
Compounding dissociative effects can cause confusion, mania, and loss of motor control